Adcock CEO upbeat about increased drug sales with NHI

The CEO of South Africa’s second-largest generic drug manufacturer, Adcock Ingram‘s Andy Hall, has sought to allay fears that the government’s drive for universal health coverage poses a risk to the pharmaceutical sector, saying the reforms proposed under the National Health Insurance (NHI) Bill could boost drug sales. According to a Business Live report, this view is in contrast to the negative investor sentiment that greeted the release of the bill…..more